Takeshige, Tomohito
Koyama, Ryo
Motomura, Hiroaki
Okajima, Akifumi
Nishioki, Toshihiko
Watanabe, Junko
Yae, Toshifumi
Kido, Kenji
Takahashi, Kazuhisa
Article History
Received: 20 June 2024
Accepted: 1 December 2024
First Online: 18 December 2024
Declarations
:
: Not applicable.
: Consent for publication was obtained from the patient.
: KT receives grants and personal fees from AstraZeneca, Boehringer Ingelheim, Chugai, Eli Lilly, Kyorin, MSD, Nobelpharma, Novartis, Ono, Pfizer, and Teijin; grants from Astellas, GlaxoSmithKline, Kyowa Hakko Kirin, MiZ, Mochida, Nipro, Nippon Shinyaku, Taiho, Toyama Chemical, Tsumura, Sanofi, Shionogi, and Torii; and personal fees from Bristol-Myers, Eisai, Meiji Seika, Mitsubishi Tanabe, Otsuka, Parexel, and Sumitomo Dainippon outside the submitted work. The remaining authors have no conflicts of interest to declare.